Drawing for SPOT

USPTO serial 88423009

SPOT

Reviewed by CopyMark Law Group

Reg. 5919573Status 702Registered
Filing date
Status date
Registration date
Nov 26, 2019
Examiner
COHEN, ROBERT ANDREW
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with SPOT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

RICHARD L MORRIS JR ESQ

RICHARD L MORRIS JR ESQ 1-800-4-TRADEMARK PAP.O. BOX 398538c/o TrademarkRenewals.comMIAMI BEACH, FL 33239

Goods and services

ClassDescriptionStatusFirst use
042Testing, analysis, and evaluation of medical packaging, medical device packaging, and sterile medical packaging to assure compliance with industry standards; Testing, analysis, and evaluation of medical packaging, medical device packaging, and sterile medical packaging to determine conformity with certification standardsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 10, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 10, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 10, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 21, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Mar 21, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Mar 21, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 27, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Nov 26, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 8, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 8, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 8, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 16, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 16, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 16, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 26, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 10, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 10, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 21, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 30, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 24, 2019DOCKASSIGNED TO EXAMINER—
May 29, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 13, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance